Depressive symptoms and exposure to efavirenz in West African HIV-infected adults.
Marcellin
Fabienne
F
Moh
Raoul
R
Carrieri
Maria Patrizia
MP
Danel
Christine
C
Protopopescu
Camelia
C
Gabillard
Delphine
D
Spire
Bruno
B
Anglaret
Xavier
X
D000328:Adult; D000354:Africa, Western / Q000453:epidemiology; D000480:Alkynes; D019380:Anti-HIV Agents / Q000008:administration & dosage*; D048588:Benzoxazines / Q000008:administration & dosage*; D003521:Cyclopropanes; D003863:Depression / Q000453:epidemiology* / Q000503:physiopathology; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000503:physiopathology / Q000523:psychology; D015497:HIV-1 / Q000187:drug effects; D006801:Humans; D007407:Interviews as Topic; D019259:Lamivudine / Q000008:administration & dosage; D008297:Male; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage*; D016896:Treatment Outcome; D015215:Zidovudine / Q000008:administration & dosage
D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; D015215:Zidovudine; C098320:efavirenz